CD4 and myeloid sarcoma: Increased Bcl-2 expression may also have relevance for MS susceptibility; overexpression of β-arrestin 1, a positive regulator of Bcl-2 expression, increases susceptibility to EAE, and CD4 T cells in MS have increased expression of β-arrestin 1 [29].